The World Health Organization defines MPD with eosinophilia and constitutively activated platelet-derived growth factor receptor-α, or -β, or fibroblast growth factor receptor 1 as a distinct category [39]. The gene discussed is FGFR1; the disease is myeloproliferative neoplasm.